IJ Pharmaceutical Research
Crossref
1. Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
- Sareh Kamran
- Ajantha Sinniah
- Zamri Chik
- Mohammed Abdullah Alshawsh
2. Unveiling a sustainable approach to cancer treatment: the antitumor activity of amygdalin and cell-free supernatant of Lacticaseibacillus rhamnosus
- Omnia Karem M. Riad
- Hagar F. Forsan
- Basma Abdulsamad
- Heba Mohammed Refat M. Selim
- Wafaa S. Khalaf
3. Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial
- Nesreen M. Sabry
- Tamer M. Naguib
- Ahmed M. Kabel
- El-Sayed Khafagy
- Hany H. Arab
- Walid A. Almorsy
4. Outcome of FOLFOX and Modified DCF Chemotherapy Regimen in Patients with Advanced Gastric Adenocarcinoma
- Mehdi Pourghasemian
- Amin Danandeh Mehr
- Mohammad Molaei
- Afshin Habibzadeh
5. Optimizing care for gastric cancer with overt bleeding: Is systemic therapy a valid option?
- Emad Qayed
6. Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment
- Fatih Gürler
- Ayşegül İlhan
- Deniz Can Güven
- Okan Turhan
- Bediz Kurt İnci
- Osman Sütçüoğlu
- Fatih Yildiz
- Zafer Arik
- Berna Öksüzoğlu
- Şuayib Yalçin
- Nuriye Özdemir
- Ozan Yazici
- Ahmet Özet
7. Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis
- Yan-Hong Yao
- Hua Zhang
- Yu Xiao
- Zhen-Tao Liu
- Yan-Yan Shi
- Jin-Yu Yu
- Qian Li
- Bao-Shan Cao
8. MnO2-shelled Doxorubicin/Curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy
- Jie Liu
- Li Li
- Bing Zhang
- Zhi Ping Xu